EX-23.1 4 exhibit23-1.htm EXHIBIT 23.1
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the following Registration Statements:

(1) | Registration Statement (Form S-3 No. 333-275741) of Ionis Pharmaceuticals, Inc., and

(2) | Registration Statements (Form S-8 Nos. 333-05825, 333-55683, 333-40336, 333-59296, 333-91572, 333-106859, 333-116962, 333-125911, 333-133853, 333-142777, 333-151996, 333-160269, 333-168674, 333-176136, 333-184788, 333-190408, 333-207900, 333-219801, 333-233143, 333-242386, 333-251855, 333-258503, 333-273902 and 333-281242) of Ionis Pharmaceuticals, Inc.;

of our reports dated February 19, 2025, with respect to the consolidated financial statements of Ionis Pharmaceuticals, Inc. and the effectiveness of internal control over financial reporting of Ionis Pharmaceuticals, Inc. included in this Annual Report (Form 10-K) of Ionis Pharmaceuticals, Inc. for the year ended December 31, 2024.

/s/ Ernst & Young LLP |
San Diego, California |
February 19, 2025 |